TH162586B - Enhanced Stability of Novel Liquid Compositions - Google Patents

Enhanced Stability of Novel Liquid Compositions

Info

Publication number
TH162586B
TH162586B TH1501004856A TH1501004856A TH162586B TH 162586 B TH162586 B TH 162586B TH 1501004856 A TH1501004856 A TH 1501004856A TH 1501004856 A TH1501004856 A TH 1501004856A TH 162586 B TH162586 B TH 162586B
Authority
TH
Thailand
Prior art keywords
liquid compositions
enhanced stability
novel liquid
approximately
pharmaceutical
Prior art date
Application number
TH1501004856A
Other languages
Thai (th)
Other versions
TH1501004856A (en
TH162586A (en
Original Assignee
ไฟเซอร์ อิงค์
Filing date
Publication date
Application filed by ไฟเซอร์ อิงค์ filed Critical ไฟเซอร์ อิงค์
Publication of TH1501004856A publication Critical patent/TH1501004856A/en
Publication of TH162586A publication Critical patent/TH162586A/en
Publication of TH162586B publication Critical patent/TH162586B/en

Links

Abstract

การประดิษฐ์ปัจจุบันเกี่ยวข้องกับองค์ประกอบของสารทางเภสัชกรรม (pharmaceutical agents) ในสารรวมกับสารทางเภสัชกรรมเพื่มเติมในสารผสมของ โพลีเอธีลีนไกลคอล, โพลีไวนิล ไพโรลิโดน, และโพรไพลีนไกลดอล และกระบวนการของการผลิตองค์ประกอบนี้ The present invention is related to the composition of the pharmaceutical substance. (pharmaceutical agents) in substances combined with pharmaceutical substances to add to the mixtures of Polyethylene glycol, polyvinyl pyrolidone, and propylene glycol And the process of producing this element

Claims (1)

1. องค์ประกอบทางเภสัชกรรมชนิดของเหลวสำหรับรับประทาน (liquid oral pharmaceutical composition) ที่ประกอบรวมด้วย i) ตั้งแต่ประมาณ 0.1% ถึงประมาณ 20% น้ำหนักต่อปริมาตร โพลีไวนิลไพโรลิโดน; ii) ตั้งแต่ประมาณ 5% ถึงประมาณ 70% น้ำหนักต่อปริมาตร โพลีเอธีลีนไกลคอล;1. The liquid oral pharmaceutical composition containing i) ranges from approximately 0.1% to approximately 20% weight per volume. Polyvinyl pyrolidone; ii) From approximately 5% to approximately 70% weight per volume. Polyethylene glycol;
TH1501004856A 2014-02-13 Enhanced Stability of Novel Liquid Compositions TH162586B (en)

Publications (3)

Publication Number Publication Date
TH1501004856A TH1501004856A (en) 2017-05-25
TH162586A TH162586A (en) 2017-05-25
TH162586B true TH162586B (en) 2017-05-25

Family

ID=

Similar Documents

Publication Publication Date Title
PH12016501791A1 (en) Muscarinic receptor agonists
CL2014000511A1 (en) Compounds derived from quinazoline, selective and reversible inhibitors of ubiquitin-specific protease 7; Preparation process; pharmaceutical compositions containing them and the use in the treatment and / or prevention of diseases such as cancer.
PH12015501753A1 (en) Enhanced stability of novel liquid compositions
HRP20220075T1 (en) A liquid formulation comprising nicotine for aerosol administration
MY191590A (en) 9h-pyrrolo-dipyridine derivatives
MA43574A (en) COMPOSITIONS WITH PERMEATION AMPLIFIERS FOR THE DELIVERY OF MEDICINAL PRODUCTS
WO2015011694A3 (en) Isotopologues of smad7 antisense oligonucleotides
CL2015002897A1 (en) Bace1 inhibitors
MA49116A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING INSULIN
EA201590491A1 (en) IMMUNOGENIC COMPOSITION
CL2016001937A1 (en) Functionalized benzopyran compounds and their use
MX2018013742A (en) Crystal forms of crisaborole in free form and preparation method and use thereof.
EA201500821A1 (en) Derivatives of 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purines, their use as pharmaceuticals and pharmaceutical compounds
TR201902741T4 (en) Personal Cleaning Compositions
AR100453A1 (en) COMPOSITIONS FOR ORAL CARE CONTAINING POLYETHYLENE GLYCOL FOR PHYSICAL STABILITY
BR112015013675A2 (en) compositions comprising vortioxetine and donepezil
SA516370737B1 (en) Formulations for CGRP Receptor Antagonists
MA49947A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA-AMYLOID ANTIBODIES
GB201611175D0 (en) Liquid pharmaceutical composition of clonidine
EA201892376A1 (en) COMBINED COMPOSITION OF THREE ANTI-VIRUS COMPOUNDS
TH162586B (en) Enhanced Stability of Novel Liquid Compositions
EA201892157A1 (en) PHOSPHAPLATIN LIQUID COMPOSITIONS
TH162586A (en) Enhanced Stability of Novel Liquid Compositions
FR3007654B1 (en) ORAL REHYDRATION SOLUTE COMPOSITION CONTAINING PROBIOTICS
EA201991190A1 (en) PHARMACEUTICAL COMPLEX PRODUCT CONTAINING AMLODIPINE, LOZARTAN AND ROSUVASTATIN